GEA
IHI icon

Glen Eagle Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Glen Eagle Advisors’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Sell
3,453
-119
-3% -$6.04K 0.02% 292
2026
Q1 		$191K Sell
3,572
-239
-6% -$14K 0.03% 269
2025
Q4 		$237K Sell
3,811
-346
-8% -$21.4K 0.03% 245
2025
Q3 		$250K Sell
4,157
-179
-4% -$10.9K 0.03% 243
2025
Q2 		$272K Buy
4,336
+15
+0.3% +$901 0.04% 219
2025
Q1 		$260K Sell
4,321
-1,092
-20% -$67.8K 0.04% 224
2024
Q4 		$316K Sell
5,413
-484
-8% -$28.8K 0.05% 194
2024
Q3 		$349K Sell
5,897
-1,589
-21% -$90.7K 0.06% 181
2024
Q2 		$420K Sell
7,486
-449
-6% -$25.1K 0.08% 151
2024
Q1 		$465K Buy
7,935
+100
+1% +$5.65K 0.09% 149
2023
Q4 		$423K Buy
7,835
+1
+0% +$49 0.09% 154
2023
Q3 		$380K Hold
7,834
– – 0.09% 152
2023
Q2 		$442K Sell
7,834
-239
-3% -$13.2K 0.1% 151
2023
Q1 		$436K Hold
8,073
– – 0.11% 140
2022
Q4 		$424K Hold
8,073
– – 0.12% 141
2022
Q3 		$381K Buy
8,073
+1
+0% +$52 0.11% 147
2022
Q2 		$407K Sell
8,072
-137
-2% -$7.47K 0.11% 152
2022
Q1 		$500K Hold
8,209
– – 0.13% 142
2021
Q4 		$541K Hold
8,209
– – 0.14% 140
2021
Q3 		$515K Buy
8,209
+1
+0% +$64 0.15% 136
2021
Q2 		$494K Hold
8,208
– – 0.15% 130
2021
Q1 		$452K Buy
8,208
+660
+9% +$36.6K 0.16% 118
2020
Q4 		$412K Buy
7,548
+2,850
+61% +$149K 0.16% 116
2020
Q3 		$235K Buy
4,698
+870
+23% +$42.1K 0.11% 145
2020
Q2 		$169K Buy
3,828
+3,228
+538% +$138K 0.09% 164
2020
Q1 		$22.5K Hold
600
– – 0.02% 388
2019
Q4 		$26.4K Buy
+600
New +$25.2K 0.01% 420

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Glen Eagle Advisors's IHI Position: Q2 2026 in Review

Glen Eagle Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 3.3% in Q2 2026, selling an estimated $6.04K and leaving 3,453 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #292.

Glen Eagle Advisors first reported a position in IHI in Q4 2019 and has held it in 27 quarters since. The position peaked at $541K in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Glen Eagle Advisors held 3,453 shares of iShares US Medical Devices ETF worth $171K as of Q2 2026.
  • Glen Eagle Advisors sold 119 iShares US Medical Devices ETF shares in Q2 2026, an estimated $6.04K.
  • iShares US Medical Devices ETF made up 0.02% of Glen Eagle Advisors's portfolio in Q2 2026, its #292 holding.
  • Glen Eagle Advisors first reported a position in iShares US Medical Devices ETF in Q4 2019 and has held it in 27 quarters since.
  • Glen Eagle Advisors's iShares US Medical Devices ETF position peaked at $541K in Q4 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.